tradingkey.logo

Sanara Medtech Inc

SMTI
20.240USD
+0.200+1.00%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
180.76MValor de mercado
PerdaP/L TTM

Sanara Medtech Inc

20.240
+0.200+1.00%

Mais detalhes de Sanara Medtech Inc Empresa

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Informações de Sanara Medtech Inc

Código da empresaSMTI
Nome da EmpresaSanara Medtech Inc
Data de listagemApr 07, 1994
CEOMuppalla (Suresh V)
Número de funcionários141
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 07
Endereço1200 Summit Avenue
CidadeFORT WORTH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal76102
Telefone18175292300
Sitehttps://sanaramedtech.com/
Código da empresaSMTI
Data de listagemApr 07, 1994
CEOMuppalla (Suresh V)

Executivos da empresa Sanara Medtech Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+28563.00%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+2809.00%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+3277.00%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+3590.00%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+3277.00%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+2965.00%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
+2973.00%
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+28563.00%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+2809.00%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+3277.00%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+3590.00%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+3277.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Soft tissue repair products
23.42M
88.95%
Bone fusion products
2.91M
11.05%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Soft tissue repair products
23.42M
88.95%
Bone fusion products
2.91M
11.05%

Distribuição de ações

Atualizado em: dom, 8 de fev
Atualizado em: dom, 8 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Baird Financial Corp
8.51%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
Outro
30.14%
Investidores
Investidores
Proporção
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Baird Financial Corp
8.51%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
Outro
30.14%
Tipos de investidores
Investidores
Proporção
Corporation
53.55%
Individual Investor
20.27%
Investment Advisor
6.62%
Investment Advisor/Hedge Fund
4.46%
Research Firm
0.98%
Hedge Fund
0.78%
Bank and Trust
0.11%
Pension Fund
0.11%
Outro
13.11%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
118
1.18M
13.21%
-21.61K
2025Q3
109
1.11M
12.48%
-19.18K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
FA Sanara, L.L.C.
3.51M
39.3%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.82%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.74%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.49%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
182.03K
2.04%
+6.05K
+3.44%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
169.88K
1.9%
-17.22K
-9.20%
Sep 30, 2025
Stonebridge Wealth Management, LLC
134.93K
1.51%
+20.35K
+17.76%
Dec 31, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
78.50K
0.88%
+764.00
+0.98%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
Ver Mais
Texas Capital Texas Small Cap Equity Index ETF
Proporção0.05%
WisdomTree US SmallCap Fund
Proporção0.03%
iShares Micro-Cap ETF
Proporção0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0%
Dimensional US Core Equity 1 ETF
Proporção0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Global X Russell 2000 Covered Call ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI